High level of plasma endothelin-1 predicts development of hypertension in normotensive subjects

American Journal of Hypertension

Volumn 23, Issue 10, 2010, Pages 1103-1107

  Kumagae, Shun Ichi ^a   Adachi, Hisashi ^a   Jacobs Jr , David R ^b   Hirai, Yuji ^a   Enomoto, Mika ^a   Fukami, Ako ^a   Otsuka, Maki ^a   Nanjo, Yasuki ^a   Esaki, Eishi ^a   Kumagai, Eita ^a   Yoshikawa, Kuniko ^a   Yokoi, Kanako ^a   Ogata, Kinuka ^a   Tsukagawa, Eri ^a   Kasahara, Akiko ^a   Murayama, Kyoko ^a   Imaizumi, Tsutomu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

blood pressure; endothelium; epidemiology; hypertension; prospective study; Seven Countries Study; Tanushimaru

Indexed keywords

ENDOTHELIN 1;

ADULT; ARTICLE; BLOOD CHEMISTRY; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; BODY MASS; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ENDOTHELIN-1; FEMALE; HUMANS; HYPERTENSION; JAPAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 77956873797     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2010.125     Document Type: Article

References (26)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415.
2. Levin ER. Endothelins. N Engl J Med 1995; 333:356-363.
3. Schiffrin EL. Endothelin and endothelin antagonists in hypertension. J Hypertens 1998; 16:1891-1895.
4. Schiffrin EL. Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 2001; 14:83S-89S.
5. Kon V, Yoshioka T, Fogo A, Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest 1989; 83:1762-1767.
6. Pollock DM, Opgenorth TJ. Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation. Am J Physiol 1993; 264:R222-R226.
7. Masaki T, Kimura S, Yanagisawa M, Goto K. Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation 1991; 84:1457-1468.
8. Saito Y, Nakao K, Mukoyama M, Imura H. Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 1990; 322:205.
9. Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Fukui T, Takeda T. Plasma immunoreactive endothelin in essential hypertension. Am J Med 1990; 88:614-618.
10. Saito Y, Nakao K, Mukoyama M, Shirakami G, Itoh H, Yamada T, Arai H, Hosoda K, Suga S, Jougasaki M. Application of monoclonal antibodies for endothelin to hypertensive research. Hypertension 1990; 15:734-738.
11. Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Dickerson C, Nunez DJ, Capper SJ, Brown MJ. A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci 1990; 78:261-264.
12. Miyauchi T, Yanagisawa M, Iida K, Ajisaka R, Suzuki N, Fujino M, Goto K, Masaki T, Sugishita Y. Age- and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive subjects. Am Heart J 1992; 123:1092-1093.
13. Hirai Y, Adachi H, Fujiura Y, Hiratsuka A, Enomoto M, Imaizumi T. Plasma endothelin-1 level is related to renal function and smoking status but not to blood pressure: an epidemiological study. J Hypertens 2004; 22:713-718.
14. Koga Y, Hashimoto R, Adachi H, Tsuruta M, Tashiro T, Toshima H. Recent trends in cardiovascular disease and risk factors in the Seven Countries Study: Lessons for science from the Seven Countries Study. In: Keys A, Toshima H, Blackburn H (eds), A 35-Year Collaborative Experience in Cardiovascular Disease Epidemiology. Springer Verlag: Tokyo, Japan, 1994, pp. 63-74.
15. Hino A, Adachi H, Toyomasu K, Yoshida N, Enomoto M, Hiratsuka A, Hirai Y, Satoh A, Imaizumi T. Very long chain N-3 fatty acids intake and carotid atherosclerosis: an epidemiological study evaluated by ultrasonography. Atherosclerosis 2004; 176:145-149.
16. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53:982-992.
17. Ando K, Hirata Y, Shichiri M, Emori T, Marumo F. Presence of immunoreactive endothelin in human plasma. FEBS Lett 1989; 245:164-166.
18. Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. N Engl J Med 1998; 338:784-790.
19. Cooper DC, Mills PJ, Bardwell WA, Ziegler MG, Dimsdale JE. The effects of ethnic discrimination and socioeconomic status on endothelin-1 among blacks and whites. Am J Hypertens 2009; 22:698-704.
20. Schiffrin EL, Thibault G. Plasma endothelin in human essential hypertension. Am J Hypertens 1991; 4:303-308.
21. Cardillo C, Kilcoyne CM, Waclawiw M, Cannon RO 3rd, Panza JA. Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension 1999; 33:753-758.
22. Grubbs AL, Ergul A. A review of endothelin and hypertension in African-American individuals. Ethn Dis 2001; 11:741-748.
23. Oishi S, Sasaki M, Sato T. Elevated immunoreactive endothelin levels in patients with pheochromocytoma. Am J Hypertens 1994; 7:717-722.
24. Dhaun N, Goddard J, Kohan DE, Pollock DM, Schiffrin EL, Webb DJ. Role of endothelin-1 in clinical hypertension: 20 years on. Hypertension 2008; 52: 452-459.
25. Shichiri M, Hirata Y, Ando K, Emori T, Ohta K, Kimoto S, Ogura M, Inoue A, Marumo F. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension 1990; 15:493-496.
26. Ottosson-Seeberger A, Ahlborg G, Hemsn A, Lundberg JM, Alvestrand A. Hemodynamic effects of endothelin-1 and big endothelin-1 in chronic hemodialysis patients. J Am Soc Nephrol 1999; 10:1037-1044.